143 related articles for article (PubMed ID: 18816636)
1. Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis.
Mocellin S; Nitti D
Cancer; 2008 Nov; 113(9):2398-407. PubMed ID: 18816636
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor FokI, BsmI, TaqI, ApaI, and EcoRV polymorphisms and susceptibility to melanoma: a meta-analysis.
Lee YH; Gyu Song G
J BUON; 2015; 20(1):235-43. PubMed ID: 25778322
[TBL] [Abstract][Full Text] [Related]
3. Association of Vitamin D Receptor Gene Polymorphisms With Melanoma Risk: A Meta-analysis and Systematic Review.
Birke M; Schöpe J; Wagenpfeil S; Vogt T; Reichrath J
Anticancer Res; 2020 Feb; 40(2):583-595. PubMed ID: 32014899
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.
Coşkun S; Şimşek Ş; Camkurt MA; Çim A; Çelik SB
Gene; 2016 Aug; 588(2):109-14. PubMed ID: 27155524
[TBL] [Abstract][Full Text] [Related]
5. Melanoma risk is associated with vitamin D receptor gene polymorphisms.
Zeljic K; Kandolf-Sekulovic L; Supic G; Pejovic J; Novakovic M; Mijuskovic Z; Magic Z
Melanoma Res; 2014 Jun; 24(3):273-9. PubMed ID: 24638155
[TBL] [Abstract][Full Text] [Related]
6. Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma.
Mandelcorn-Monson R; Marrett L; Kricker A; Armstrong BK; Orlow I; Goumas C; Paine S; Rosso S; Thomas N; Millikan RC; Pole JD; Cotignola J; Rosen C; Kanetsky PA; Lee-Taylor J; Begg CB; Berwick M
Cancer Epidemiol; 2011 Dec; 35(6):e105-10. PubMed ID: 21612999
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and skin cancer: a meta-analysis.
Gandini S; Raimondi S; Gnagnarella P; Doré JF; Maisonneuve P; Testori A
Eur J Cancer; 2009 Mar; 45(4):634-41. PubMed ID: 19008093
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma.
Hutchinson PE; Osborne JE; Lear JT; Smith AG; Bowers PW; Morris PN; Jones PW; York C; Strange RC; Fryer AA
Clin Cancer Res; 2000 Feb; 6(2):498-504. PubMed ID: 10690530
[TBL] [Abstract][Full Text] [Related]
9. ApaI, BsmI, FokI and TaqI polymorphisms in the vitamin D receptor (VDR) gene and the risk of psoriasis: a meta-analysis.
Liu JL; Zhang SQ; Zeng HM
J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):739-46. PubMed ID: 22540341
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.
Randerson-Moor JA; Taylor JC; Elliott F; Chang YM; Beswick S; Kukalizch K; Affleck P; Leake S; Haynes S; Karpavicius B; Marsden J; Gerry E; Bale L; Bertram C; Field H; Barth JH; Silva Idos S; Swerdlow A; Kanetsky PA; Barrett JH; Bishop DT; Bishop JA
Eur J Cancer; 2009 Dec; 45(18):3271-81. PubMed ID: 19615888
[TBL] [Abstract][Full Text] [Related]
11. Association between vitamin D receptor BsmI, FokI, and Cdx2 polymorphisms and osteoporosis risk: an updated meta-analysis.
Chen B; Zhu WF; Mu YY; Liu B; Li HZ; He XF
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627819
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor gene and risk of fracture in postmenopausal women: a meta-analysis.
Shen H; Xie J; Lu H
Climacteric; 2014 Aug; 17(4):319-24. PubMed ID: 24156276
[TBL] [Abstract][Full Text] [Related]
13. Association between VDR polymorphisms and rheumatoid arthritis disease: Systematic review and updated meta-analysis of case-control studies.
Tizaoui K; Hamzaoui K
Immunobiology; 2015 Jun; 220(6):807-16. PubMed ID: 25577294
[TBL] [Abstract][Full Text] [Related]
14. BsmI, TaqI, ApaI, and FokI polymorphisms in the vitamin D receptor gene and periodontitis: a meta-analysis of 15 studies including 1338 cases and 1302 controls.
Deng H; Liu F; Pan Y; Jin X; Wang H; Cao J
J Clin Periodontol; 2011 Mar; 38(3):199-207. PubMed ID: 21198767
[TBL] [Abstract][Full Text] [Related]
15. Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism.
Santonocito C; Capizzi R; Concolino P; Lavieri MM; Paradisi A; Gentileschi S; Torti E; Rutella S; Rocchetti S; Di Carlo A; Di Stasio E; Ameglio F; Zuppi C; Capoluongo E
Br J Dermatol; 2007 Feb; 156(2):277-82. PubMed ID: 17223867
[TBL] [Abstract][Full Text] [Related]
16. Contribution of VDR polymorphisms to type 1 diabetes susceptibility: Systematic review of case-control studies and meta-analysis.
Tizaoui K; Kaabachi W; Hamzaoui A; Hamzaoui K
J Steroid Biochem Mol Biol; 2014 Sep; 143():240-9. PubMed ID: 24742873
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor gene ApaI, TaqI, FokI and BsmI polymorphisms in a group of Turkish patients with Hashimoto's thyroiditis.
Yazici D; Yavuz D; Tarcin O; Sancak S; Deyneli O; Akalin S
Minerva Endocrinol; 2013 Jun; 38(2):195-201. PubMed ID: 23732374
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma.
Li C; Liu Z; Zhang Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
J Invest Dermatol; 2007 Feb; 127(2):276-80. PubMed ID: 16990805
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.
Serrano D; Gnagnarella P; Raimondi S; Gandini S
Eur J Cancer Prev; 2016 Jan; 25(1):85-96. PubMed ID: 25738688
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis.
Fang Y; Rivadeneira F; van Meurs JB; Pols HA; Ioannidis JP; Uitterlinden AG
Bone; 2006 Oct; 39(4):938-45. PubMed ID: 16769262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
